A modern clinical decision support system (CDSS) leveraging artificial intelligence (AI) is demonstrating significant improvements in stroke care quality and long-term patient outcomes, according to a recent study published in The BMJ. The system, designed to analyze brain scans and provide treatment recommendations, offers a potentially scalable and cost-effective solution for enhancing stroke management, particularly in regions with limited resources.
Stroke remains a leading cause of disability and death worldwide, and rapid, accurate diagnosis and treatment are critical for minimizing long-term effects. While AI has shown promise in healthcare, particularly in areas like image analysis and clinical decision-making, rigorous evaluation of these tools in real-world settings has been limited. This new research addresses that gap, focusing on the impact of an AI-assisted CDSS on acute ischemic stroke care in China.
The study, known as GOLDEN BRIDGE II, involved a large-scale trial encompassing 21,603 patients with acute ischemic stroke admitted to 77 hospitals across China between January 2021 and June 2023. Patients, with an average age of 67 and 36% female, were evaluated within seven days of experiencing stroke symptoms. Researchers compared outcomes for 11,054 patients who received support from the stroke CDSS (intervention group) with those of 10,549 patients who received standard medical care (control group).
The AI-powered CDSS assists physicians by classifying the causes of stroke using AI-assisted imaging analysis and providing evidence-based treatment recommendations. The system was integrated into existing hospital information systems and physicians in the intervention group received training on its use, taking into account factors like hospital location, patient age, medical history, and lifestyle.
Reduced Vascular Events with AI Assistance
The results showed a statistically significant reduction in new vascular events – including stroke, heart attack, or related death – among patients supported by the CDSS. At three months, 2.9% of patients in the intervention group (320 of 11,054) experienced a new vascular event, compared to 3.9% in the control group (416 of 10,549), representing a 26% reduction. This benefit was sustained at 12 months, with rates of 4% and 5.5% respectively, a 27% reduction. These findings suggest that the CDSS can contribute to improved long-term cardiovascular health for stroke survivors.
Beyond reducing vascular events, patients receiving the intervention too demonstrated higher scores on measures of stroke care quality, achieving 91.4% compared to 89.8% in the control group. However, the study found no significant differences between the groups in terms of disability or all-cause mortality at three, six, or 12 months. Similarly, there were no significant differences in bleeding rates between the two groups.
Hospital-Level Randomization and System Integration
It’s important to note that the trial randomized hospitals, rather than individual patients, which the authors acknowledge as a limitation. Differences in post-hospital care and overall care patterns could influence the observed outcomes. However, the researchers emphasized the system’s ease of use and seamless integration into existing hospital workflows. They suggest it could serve as a comprehensive AI-based management tool, focusing on both in-hospital care and secondary prevention strategies.
The authors conclude that the stroke CDSS represents a “promising approach” to delivering high-quality care for patients with acute ischemic stroke, particularly in regions like China, which face a substantial burden of cerebrovascular disease. The study, published in The BMJ, highlights the potential of AI to improve stroke care and outcomes on a large scale.
Looking ahead, further research will be crucial to assess the long-term impact of this technology and to explore its applicability in diverse healthcare settings. The development and implementation of AI-powered tools like this CDSS could play a vital role in addressing the global challenge of stroke and improving the lives of millions of patients.
What are your thoughts on the role of AI in healthcare? Share your comments below, and please share this article with your network.
Disclaimer: This article provides informational content and should not be considered medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.
